WallStreetZenWallStreetZen

NASDAQ: SLRX
Salarius Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Salarius Pharmaceuticals earnings were -$5.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest SLRX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$957.8k, down 44% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLRX reported annual earnings of -$5.6M, with -55.5% growth.

SLRX earnings history

Current Revenue
$0.0
Current Earnings
-$5.1M
Current Profit Margin
0%

SLRX Return on Equity

Current Company
-556.5%
Current Industry
-10%
Current Market
30.7%
SLRX's Return on Equity (-556.5%)... subscribe to Premium to read more.
High Return on Equity Performance

SLRX undefined

Current Company
-192.3%
Current Industry
-0.2%
SLRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SLRX announces earnings.

SLRX undefined

Current Company
615.07%
Current Industry
6.4%
SLRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SLRX-$5.10M-$5.10MN/A-$43.50
VRAX-$5.91M-$6.06MN/A-$1.62
AZTR-$8.89M-$9.36MN/A-$2.07
GTBP-$9.40M-$9.48MN/A-$4.07
INM-$7.40M-$8.31MN/A-$12.09
View Top Biotech Stocks

Salarius Pharmaceuticals Earnings Reports & History FAQ

What were Salarius Pharmaceuticals's earnings last quarter?

Salarius Pharmaceuticals (NASDAQ: SLRX) reported Q2 2025 earnings per share (EPS) of -$6.75, up 81.01% year over year. Total SLRX earnings for the quarter were -$957.83 thousand. In the same quarter last year, Salarius Pharmaceuticals's earnings per share (EPS) was -$35.55.

If you're new to stock investing, here's how to buy Salarius Pharmaceuticals stock.

Is Salarius Pharmaceuticals profitable or losing money?

As of the last Salarius Pharmaceuticals earnings report, Salarius Pharmaceuticals is currently losing money. Salarius Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$5.10 million, a 21.05% decrease year over year.

What was SLRX's earnings growth in the past year?

As of Salarius Pharmaceuticals's earnings date in Q3 2025, Salarius Pharmaceuticals's earnings has grown year over year. SLRX earnings in the past year totalled -$5.10 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.